Eton Pharmaceuticals, Inc. (ETON) › Cash & EquivalentsEton Pharmaceuticals, Inc. (ETON) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2017: $13.16M2018: $26.73M2019: $12.07M2020: $21.30M2021: $14.41M2022: $16.30M2023: $21.39M2024: $14.94M2025: $25.94M$25.94M2017Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$25.94M+73.7%2024$14.94M-30.2%2023$21.39M+31.2%2022$16.30M+13.2%2021$14.41M-32.4%2020$21.30M+76.5%2019$12.07M-54.9%2018$26.73M+103.2%2017$13.16M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share